Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: E9AXG8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 138 | 140 | PF00675 | 0.711 |
CLV_NRD_NRD_1 | 252 | 254 | PF00675 | 0.269 |
CLV_PCSK_KEX2_1 | 138 | 140 | PF00082 | 0.681 |
CLV_PCSK_KEX2_1 | 252 | 254 | PF00082 | 0.304 |
DEG_APCC_DBOX_1 | 252 | 260 | PF00400 | 0.472 |
DEG_SCF_FBW7_1 | 237 | 244 | PF00400 | 0.676 |
DEG_SPOP_SBC_1 | 285 | 289 | PF00917 | 0.454 |
DOC_ANK_TNKS_1 | 233 | 240 | PF00023 | 0.686 |
DOC_MAPK_gen_1 | 252 | 259 | PF00069 | 0.469 |
DOC_MAPK_MEF2A_6 | 252 | 261 | PF00069 | 0.525 |
DOC_USP7_MATH_1 | 241 | 245 | PF00917 | 0.670 |
DOC_USP7_MATH_1 | 290 | 294 | PF00917 | 0.506 |
DOC_USP7_MATH_1 | 313 | 317 | PF00917 | 0.467 |
DOC_USP7_UBL2_3 | 89 | 93 | PF12436 | 0.644 |
DOC_WW_Pin1_4 | 223 | 228 | PF00397 | 0.708 |
DOC_WW_Pin1_4 | 237 | 242 | PF00397 | 0.613 |
DOC_WW_Pin1_4 | 243 | 248 | PF00397 | 0.650 |
DOC_WW_Pin1_4 | 274 | 279 | PF00397 | 0.426 |
DOC_WW_Pin1_4 | 329 | 334 | PF00397 | 0.459 |
LIG_14-3-3_CanoR_1 | 252 | 257 | PF00244 | 0.455 |
LIG_14-3-3_CanoR_1 | 312 | 322 | PF00244 | 0.505 |
LIG_14-3-3_CanoR_1 | 9 | 15 | PF00244 | 0.516 |
LIG_APCC_ABBA_1 | 233 | 238 | PF00400 | 0.691 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.545 |
LIG_DLG_GKlike_1 | 252 | 259 | PF00625 | 0.484 |
LIG_eIF4E_1 | 15 | 21 | PF01652 | 0.205 |
LIG_eIF4E_1 | 67 | 73 | PF01652 | 0.325 |
LIG_FHA_1 | 186 | 192 | PF00498 | 0.504 |
LIG_FHA_1 | 329 | 335 | PF00498 | 0.406 |
LIG_FHA_1 | 80 | 86 | PF00498 | 0.308 |
LIG_FHA_2 | 48 | 54 | PF00498 | 0.365 |
LIG_LIR_Gen_1 | 13 | 22 | PF02991 | 0.363 |
LIG_LIR_Gen_1 | 201 | 210 | PF02991 | 0.268 |
LIG_LIR_Gen_1 | 36 | 41 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 13 | 18 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 201 | 205 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 245 | 251 | PF02991 | 0.661 |
LIG_LIR_Nem_3 | 36 | 40 | PF02991 | 0.444 |
LIG_LIR_Nem_3 | 66 | 70 | PF02991 | 0.269 |
LIG_SH2_CRK | 15 | 19 | PF00017 | 0.253 |
LIG_SH2_PTP2 | 108 | 111 | PF00017 | 0.325 |
LIG_SH2_PTP2 | 202 | 205 | PF00017 | 0.392 |
LIG_SH2_PTP2 | 67 | 70 | PF00017 | 0.325 |
LIG_SH2_STAP1 | 15 | 19 | PF00017 | 0.304 |
LIG_SH2_STAP1 | 152 | 156 | PF00017 | 0.458 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.304 |
LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.458 |
LIG_SH2_STAT5 | 202 | 205 | PF00017 | 0.392 |
LIG_SH2_STAT5 | 26 | 29 | PF00017 | 0.372 |
LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.284 |
LIG_SH3_3 | 221 | 227 | PF00018 | 0.569 |
LIG_SUMO_SIM_anti_2 | 16 | 23 | PF11976 | 0.270 |
LIG_SUMO_SIM_anti_2 | 215 | 221 | PF11976 | 0.300 |
LIG_SUMO_SIM_anti_2 | 36 | 45 | PF11976 | 0.319 |
LIG_SUMO_SIM_par_1 | 18 | 23 | PF11976 | 0.311 |
LIG_TYR_ITIM | 200 | 205 | PF00017 | 0.462 |
LIG_WW_3 | 164 | 168 | PF00397 | 0.402 |
MOD_CK1_1 | 243 | 249 | PF00069 | 0.588 |
MOD_CK1_1 | 277 | 283 | PF00069 | 0.496 |
MOD_CK2_1 | 198 | 204 | PF00069 | 0.460 |
MOD_CK2_1 | 329 | 335 | PF00069 | 0.406 |
MOD_CMANNOS | 28 | 31 | PF00535 | 0.493 |
MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.611 |
MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.325 |
MOD_GlcNHglycan | 154 | 157 | PF01048 | 0.674 |
MOD_GlcNHglycan | 192 | 195 | PF01048 | 0.634 |
MOD_GlcNHglycan | 279 | 282 | PF01048 | 0.713 |
MOD_GlcNHglycan | 288 | 291 | PF01048 | 0.651 |
MOD_GlcNHglycan | 292 | 295 | PF01048 | 0.734 |
MOD_GlcNHglycan | 309 | 312 | PF01048 | 0.624 |
MOD_GlcNHglycan | 313 | 316 | PF01048 | 0.722 |
MOD_GlcNHglycan | 49 | 53 | PF01048 | 0.631 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.632 |
MOD_GlcNHglycan | 89 | 92 | PF01048 | 0.444 |
MOD_GSK3_1 | 237 | 244 | PF00069 | 0.676 |
MOD_GSK3_1 | 286 | 293 | PF00069 | 0.565 |
MOD_GSK3_1 | 307 | 314 | PF00069 | 0.592 |
MOD_N-GLC_1 | 259 | 264 | PF02516 | 0.205 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.615 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.183 |
MOD_NEK2_1 | 259 | 264 | PF00069 | 0.339 |
MOD_NEK2_1 | 286 | 291 | PF00069 | 0.463 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.526 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.361 |
MOD_NEK2_2 | 10 | 15 | PF00069 | 0.248 |
MOD_OFUCOSY | 184 | 189 | PF10250 | 0.589 |
MOD_PIKK_1 | 140 | 146 | PF00454 | 0.494 |
MOD_PKA_1 | 252 | 258 | PF00069 | 0.455 |
MOD_PKA_2 | 252 | 258 | PF00069 | 0.458 |
MOD_PKA_2 | 311 | 317 | PF00069 | 0.474 |
MOD_PKA_2 | 47 | 53 | PF00069 | 0.449 |
MOD_PKB_1 | 46 | 54 | PF00069 | 0.361 |
MOD_Plk_2-3 | 198 | 204 | PF00069 | 0.411 |
MOD_Plk_4 | 10 | 16 | PF00069 | 0.302 |
MOD_Plk_4 | 198 | 204 | PF00069 | 0.428 |
MOD_Plk_4 | 252 | 258 | PF00069 | 0.455 |
MOD_Plk_4 | 264 | 270 | PF00069 | 0.350 |
MOD_Plk_4 | 79 | 85 | PF00069 | 0.299 |
MOD_ProDKin_1 | 223 | 229 | PF00069 | 0.711 |
MOD_ProDKin_1 | 237 | 243 | PF00069 | 0.614 |
MOD_ProDKin_1 | 274 | 280 | PF00069 | 0.427 |
MOD_ProDKin_1 | 329 | 335 | PF00069 | 0.459 |
TRG_ENDOCYTIC_2 | 108 | 111 | PF00928 | 0.304 |
TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.304 |
TRG_ENDOCYTIC_2 | 15 | 18 | PF00928 | 0.304 |
TRG_ENDOCYTIC_2 | 202 | 205 | PF00928 | 0.419 |
TRG_ENDOCYTIC_2 | 67 | 70 | PF00928 | 0.304 |
TRG_ER_diArg_1 | 137 | 139 | PF00400 | 0.419 |
TRG_ER_diArg_1 | 251 | 253 | PF00400 | 0.669 |
TRG_ER_diLys_1 | 337 | 340 | PF00400 | 0.476 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PE40 | Leptomonas seymouri | 42% | 100% |
A0A3Q8ICA7 | Leishmania donovani | 84% | 100% |
A4HE25 | Leishmania braziliensis | 58% | 100% |
A4I1D1 | Leishmania infantum | 84% | 100% |
Q4QA04 | Leishmania major | 81% | 100% |